Product Information
BUPROPION HCL SR 150 MG TABLET is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.0827 per EA under NDC 70436005901. Its NADAC has been published 231 times since Dec 16, 2020.
Strength
150 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436005901
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
4/23/2025
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211347On Market Since
11/2/2020
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL SR 150 MG TABLET has been published 231 times since Dec 16, 2020, and over the history we have for it it has declined 28.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0827 per EA |
|---|---|
| All-time high | $0.1179 (Sep 15, 2021) |
| All-time low | $0.0709 (May 22, 2024) |
| Median price | $0.0902 |
| Average price | $0.0940 |
| Largest weekly change | +20.0% (Jun 19, 2024) |
| Weeks tracked | 231 |
| Tracking since | Dec 16, 2020 |
Generic Alternatives
The matcher finds 14 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPROPION HCL SR 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 150 MG TABLET, manufactured by Slate Run Pharmaceuticals LLC, is $0.0827 per EA (NDC 70436005901), effective May 14, 2025.
How has the price of BUPROPION HCL SR 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL SR 150 MG TABLET has declined 28.0%. It has been tracked across 231 weekly CMS publications since Dec 16, 2020.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 150 MG TABLET?
Since Dec 16, 2020, the NADAC for BUPROPION HCL SR 150 MG TABLET has ranged from a low of $0.0709 (May 22, 2024) to a high of $0.1179 (Sep 15, 2021), with a median of $0.0902 per EA.
Are there cheaper alternatives to BUPROPION HCL SR 150 MG TABLET?
Yes. 14 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BUPROPION HCL XL 150 MG TABLET, is $0.0779 per EA — about 6% below BUPROPION HCL SR 150 MG TABLET.
Who manufactures BUPROPION HCL SR 150 MG TABLET?
BUPROPION HCL SR 150 MG TABLET (NDC 70436005901) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification